The first stop for professional medicines advice

Guidance

663 results

Applied filters

Visual impairment: supporting adherence

12 December 2023Interventions and tools to help improve medication adherence, where visual impairment (capability) has been identified as a factor

Using vitamin D during breastfeeding

8 December 2023Vitamin D can be used during breastfeeding; higher doses require infant monitoring. Recommendations apply to full term, healthy infants only.

Deprescribing of antidepressants for depression and anxiety

4 December 2023Deprescribing antidepressants involves safely reducing and withdrawing them. An introduction; signposting to current resources; and SPS resources coming soon.

Purchasing Specials

30 November 2023Factors to consider when purchasing Specials and imported unlicensed medicines from commercial manufacturers

Making unlicensed medicines

30 November 2023Medicines may be made without the need for a marketing authorisation in some circumstances

Governance principles for unlicensed medicines

30 November 2023Factors to consider when unlicensed medicines are used, ensuring good governance.

Answers to frequently asked questions about Evergreen Assessments

28 November 2023We have provided guidance on the recurrent themes or topics of enquiry raised, to support implementation of the Evergreen assessment process.

Net Zero and Social Value requirements in NHSE medicines tenders

28 November 2023Guidance for using the Evergreen assessment to embed Net Zero and Social Value in NHS England medicines tenders.

Managing interactions between macrolides and statins

24 November 2023The use of statins can be continued with azithromycin. However, the interaction risks need to be managed if clarithromycin or erythromycin are required.

Deprescribing

Deprescribing is safely and effectively withdrawing inappropriate medicines. We'll soon add new content to help in practice, starting with antidepressants.
admin